logo
Sign in

ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) financials

ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20.Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus…

  • Market Cap: ₹1,12,020Cr.
  • Current Price: ₹1,123
  • Stock P/E: 30.7
  • ROE: 16.5%
  • ROCE: 16.6%
  • Book Value: ₹235
  • Dividend Yield: 0.09%
  • 52W High / Low: ₹1,232/836

In Jun 2026, ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) reported sales ₹2,872 Cr and net profit ₹340 Cr.

Annual TTM: sales ₹11,768 Cr, net profit ₹3,515 Cr.

Shareholding: Promoters 75.01% (Sep 2026), FIIs 7.05% (Sep 2026), DIIs 11.28% (Sep 2026), Government 0.00% (Sep 2026), Public 6.66% (Sep 2026).

ZYDUSLIFE quarterly results (₹ Cr.)
CategorySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales2,6212,5165,8202,5882,8712,2843,7412,872
Expenses1,6781,8672,0472,0031,7192,0851,7522,285
Operating Profit9426483,7735851,1521991,989587
OPM %36%26%65%23%40%9%53%20%
Other Income32778185157542414388124
Interest9697155138114116116103
Depreciation134132128130136144151152
Profit before tax1,0394973,6754751,4443522,111456
Tax %24%5%23%19%20%16%18%25%
Net Profit7904712,8143851,1572961,722340
EPS in Rs7.854.6827.963.8211.492.9517.113.40
Raw PDF————————
ZYDUSLIFE profit and loss (₹ Cr.)
CategoryMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6,3477,7807,8378,73210,81915,11611,48411,768
Expenses4,9165,4685,9166,2776,7607,3807,5597,841
Operating Profit1,4322,3121,9212,4544,0597,7363,9253,927
OPM %23%30%25%28%38%51%34%33%
Other Income848-102-1443451,0766961,5011,467
Interest23471135278391464483448
Depreciation429451479489504524561583
Profit before tax1,6171,6881,1642,0324,2407,4454,3824,363
Tax %13%13%26%25%19%22%19%—
Net Profit1,4131,4768581,5293,4425,7753,5603,515
EPS in Rs13.8014.428.3815.1134.2057.3935.3834.95
Dividend Payout %25%24%30%40%9%19%3%—
ZYDUSLIFE balance sheet (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital102102102102101101101101
Reserves8,46711,15812,64213,13813,53815,61621,09023,571
Borrowings3,5833,6953,9202,6654,8256,1788,3427,442
Other Liabilities1,5191,5971,7991,8352,0992,1902,7852,766
Total Liabilities13,67116,55218,46417,74020,56424,08532,31733,880
Fixed Assets3,9324,1094,1124,3364,1844,3694,2025,084
CWIP6755535703847396341,188621
Investments4,1956,4046,4715,1184,8797,28311,49211,478
Other Assets4,8685,4867,3107,90210,76111,79815,43516,696
Total Assets13,67116,55218,46417,74020,56424,08532,31733,880
ZYDUSLIFE cash flows (₹ Cr.)
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5811,1812,2271,2721,0782,0003,1142,234
Cash from Investing Activity-71355-2,714586-1,959-1,832-4,504570
Cash from Financing Activity65-967255-1,710827-3011,384-2,580
Net Cash Flow-67268-231149-54-132-5224
Free Cash Flow-1405891,7017554201,4342,2571,351
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit55%97%108%80%60%71%58%84%
ZYDUSLIFE shareholding pattern (%)
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters74.98%75.00%75.00%75.00%75.00%75.00%75.02%75.01%
FIIs7.53%7.31%7.13%7.34%7.06%6.95%6.89%7.05%
DIIs10.61%10.95%11.09%10.86%11.08%11.20%11.27%11.28%
Government0.05%0.05%0.04%0.00%0.00%0.00%0.00%0.00%
Public6.85%6.69%6.74%6.81%6.86%6.86%6.83%6.66%
No. of Shareholders3,65,3563,71,6193,86,1273,96,1054,03,2664,18,3143,99,2513,82,067
ZYDUSLIFE key ratios
CategoryMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days12814189106147160197270
Inventory Days288261276245205195236222
Days Payable137161175135120129149150
Cash Conversion Cycle279241191216232227284342
Working Capital Days81555010616416774182
ROCE %16%14%12%10%14%23%31%17%
ZYDUSLIFEUpdated 18 Oct 2026, 6:19

Zydus Lifesciences Ltd

Market Cap

₹1,12,020Cr.

Current Price

₹1,123

High / Low

₹1,232/836

Stock P/E

30.7

ROE16.5%
ROCE16.6%
Book Value₹235
Face Value₹1.00
Dividend Yield0.09%

About

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover Rs. 250 crores in 1995 the group witnessed a significant financial growth and registered a turnover of over Rs. 14,253 crores in FY20.Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address the unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days73891057912814189106147160197270
Inventory Days178127338284288261276245205195236222
Days Payable148174361173137161175135120129149150
Cash Conversion Cycle1024282190279241191216232227284342
Working Capital Days638-1013781555010616416774182
ROCE %27%38%8%15%16%14%12%10%14%23%31%17%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of ZYDUS LIFESCIENCES LTD (ZYDUSLIFE)?

The reported market capitalisation for ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) is ₹1,12,020Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of ZYDUSLIFE?

The current price shown for ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) on Fincrux is ₹1,123 with a 52-week high/low of ₹1,232/836.

What is the P/E ratio of ZYDUS LIFESCIENCES LTD (ZYDUSLIFE)?

The stock P/E for ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) is 30.7 on Fincrux, with ROE at 16.5% and ROCE at 16.6%.

What were ZYDUSLIFE latest quarterly results?

For Jun 2026, ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) reported sales ₹2,872 Cr and net profit ₹340 Cr (figures in ₹ crore unless noted).

What are ZYDUSLIFE annual sales and net profit?

For TTM, ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) shows sales of ₹11,768 Cr and net profit of ₹3,515 Cr on the Fincrux profit & loss statement.

Who owns ZYDUS LIFESCIENCES LTD (ZYDUSLIFE)?

Latest shareholding for ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) on Fincrux: Promoters 75.01% (Sep 2026), FIIs 7.05% (Sep 2026), DIIs 11.28% (Sep 2026), Government 0.00% (Sep 2026), Public 6.66% (Sep 2026).

Where can I find ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) financials?

ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show ZYDUSLIFE balance sheet and cash flow?

Yes. The ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 6:19

Designed & Shipped by Harshit Bansal